Ratings by Laidlaw
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 4/15/2026 | Yale Jen | Kazia Therapeutics | KZIA | New Coverage | Buy (N/A) |
25.00 (N/A) |
8.99 (10.95) |
21.8% | Details |
| 4/6/2026 | Yale Jen | Soleno Therapeutics Inc. | SLNO | Downgrade | Hold (Buy) |
N/A (N/A) |
39.49 (53.01) |
34.24% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 166 more... | |||||||||
